Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset ; volume:20 ; number:1 ; day:8 ; month:7 ; year:2022 ; pages:1-9 ; date:12.2022
Pediatric rheumatology ; 20, Heft 1 (8.7.2022), 1-9, 12.2022
- Creator
-
Skarin, Angelika
Berthold, Elisabet
Rauer, Ola
Bengtsson-Stigmar, Elisabeth
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-022-00704-8
- URN
-
urn:nbn:de:101:1-2022083022042061188030
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Skarin, Angelika
- Berthold, Elisabet
- Rauer, Ola
- Bengtsson-Stigmar, Elisabeth
- SpringerLink (Online service)
Other Objects (12)
Juvenile idiopathic arthritis-associated uveitis
Juvenile Uveitis
Juvenile idiopathische Arthritis: Gelenk- und Uveitis-Schübe oft gleichzeitig
Juvenile Spondyloarthritis: focus on uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
A family case of early onset juvenile idiopathic arthritis with uveitis: lessons of the past and the present
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Uveitis update
Juvenile idiopathic arthritis-associated uveitis
Juvenile Uveitis
Juvenile idiopathische Arthritis: Gelenk- und Uveitis-Schübe oft gleichzeitig
Juvenile Spondyloarthritis: focus on uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
A family case of early onset juvenile idiopathic arthritis with uveitis: lessons of the past and the present
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Uveitis update
Juvenile idiopathic arthritis-associated uveitis
Juvenile Uveitis
Juvenile idiopathische Arthritis: Gelenk- und Uveitis-Schübe oft gleichzeitig
Juvenile Spondyloarthritis: focus on uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
A family case of early onset juvenile idiopathic arthritis with uveitis: lessons of the past and the present
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis